Resverlogix Corp. (TSE:RVX – Get Free Report)’s share price crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of C$0.10 and traded as low as C$0.09. Resverlogix shares last traded at C$0.10, with a volume of 47,210 shares traded.
Resverlogix Price Performance
The company has a debt-to-equity ratio of -83.11, a quick ratio of 0.04 and a current ratio of 0.03. The firm has a market cap of C$31.62 million, a P/E ratio of -3.33 and a beta of 0.72. The company has a 50-day moving average of C$0.10 and a 200 day moving average of C$0.10.
Resverlogix (TSE:RVX – Get Free Report) last posted its earnings results on Friday, May 15th. The biotechnology company reported C$0.01 EPS for the quarter. On average, sell-side analysts anticipate that Resverlogix Corp. will post -0.22 EPS for the current year.
Resverlogix Company Profile
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Recommended Stories
- Five stocks we like better than Resverlogix
- Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
- As Small-Cap Outperformance Continues, These 2 ETFs Provide Exposure
- Silicon Shake-Up: The AI Trade Is Moving Beyond NVIDIA
- The Silver Lining of Last Week’s Hims & Hers Earnings Miss
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
